Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol-3-kinases (PI3Ks) are a family of intracellular enzymes that play a central role in cellular signaling. They are involved in regulating key cellular processes such as cell growth, proliferation, differentiation, motility, survival, and intracellular trafficking. Dysregulation of PI3K activity is implicated in various diseases, most notably cancer. PI3Ks phosphorylate the 3' hydroxyl group of the inositol ring of phosphatidylinositol lipids. The main product is phosphatidylinositol-3,4,5-trisphosphate (PIP₃), which acts as a second messenger to recruit and activate downstream signaling proteins containing pleckstrin homology (PH) domains. The tumor suppressor PTEN antagonizes PI3K by dephosphorylating PIP₃ back to PIP₂; loss or mutation of PTEN leads to hyperactivation of this pathway—a common event in cancers.
Inhibition of PI3K activity, blocking downstream signaling pathways such as AKT and mTOR.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol-3-kinase (PI3K).